Method for evaluating relative oxygen saturation in body tissues

• US 7,949,387 B2
• Filed: 03/18/2005
• Issued: 05/24/2011
• Est. Priority Date: 03/19/2004
• Status: Expired due to Fees

• Current Assignee: Board of Supervisors of Louisiana State University Agricultural & Mechanical College (Louisiana State University System)
• Original Assignee: Board of Supervisors of Louisiana State University Agricultural & Mechanical College (Louisiana State University System)
• Inventors: Khoobehi, Bahram, Beach, James M.
• Primary Examiner(s): Chen; Tse
• Assistant Examiner(s): Roy; Baisakhi
• Application Number:
  US10/593,175
• Publication Number:
  US 20080255457A1
• Time in Patent Office: 2,258 Days
• Field of Search: 600/322, 600/323, 600/475, 600/476
• US Class Current: 600/476
• CPC Class Codes: A61B 5/14555 specially adapted for the eye fundus

Abstract

A new method was discovered to analyze continuous spectral curves to determine relative hemoglobin oxygen saturation, using spectral curves collected from a continuous range of wavelengths from about 530 nm to about 584 nm, including spectra from transmitted or reflected light. Using isosbestic points and curve areas, a relative saturation index was calculated. With this method, noninvasive, in vivo measurement of relative oxygen saturation was made using light reflected from blood vessels in the eye and to map and measure relative changes in hemoglobin oxygen saturation in primate retinal vessels and optic nerve head in response to controlled changes in inspired oxygen and intraocular pressure (IOP). This method could also measure oxygen saturation from other blood vessels that reflect light sufficient to give a clear spectra from the blood hemoglobin. Changes in blood oxygen saturation can be monitored with this method for early detection of disease.

Claims

1. A method for determining hemoglobin oxygen saturation in a tissue in vivo;

said method comprising the steps of;

(a) measuring the visible reflectance spectrum or the visible absorbance spectrum of the tissue in vivo over at least a portion of the range of wavelengths between 530 nm and 584 nm;

(b) determining one or more of the values x, y, and z, wherein;

(i) x is proportional to the integral of {the reference stratum minus the measured visible spectrum} over at least a portion of region I;

(ii) y is proportional to the integral of {the measured visible spectrum minus the reference stratum} over at least a portion of region II;

(iii) z is proportional to the integral of {the reference stratum minus the measured visible spectrum} over at least a portion of region III;

(iv) region I is the region of the visible spectrum between the hemoglobin isosbestic point at about 530 nm and the hemoglobin isosbestic point at about 545 nm;

(v) region II is the region of the visible spectrum between the hemoglobin isosbestic point at about 545 nm and the hemoglobin isosbestic point at about 570 nm;

(vi) region III is the region of the visible spectrum between the hemoglobin isosbestic point at about 570 nm and the hemoglobin isosbestic point at about 584 nm;

(vii) the reference stratum comprises a sequence of three linear segments;

a first linear segment connecting the visible reflectance or absorbance of hemoglobin at the isosbestic point at about 530 nm to the visible reflectance or absorbance of hemoglobin at the isosbestic point at about 545 nm;

a second linear segment connecting the visible reflectance or absorbance of hemoglobin at the isosbestic point at about 545 nm to the visible reflectance or absorbance of hemoglobin at the isosbestic point at about 570 nm; and

a third linear segment connecting the visible reflectance or absorbance of hemoglobin at the isosbestic point at about 570 nm to the visible reflectance or absorbance of hemoglobin at the isosbestic point at about 584 nm;

whereby;

(viii) larger values of x, y, or z correspond to higher hemoglobin oxygen saturation in the tissue in vivo, and lower values of x, y, or z correspond to lower hemoglobin oxygen saturation in the tissue in vivo.

2. The method of claim 1, wherein:

(i) x is proportional to the integral of {the reference stratum minus the measured visible spectrum} over region I;

(ii) y is proportional to the integral of {the measured visible spectrum minus the reference stratum} over region II; and

(iii) z is proportional to the integral of {the reference stratum minus the measured visible spectrum} over region III.

3. The method of claim 2, additionally comprising the step of determining the sum S=x+y+z;

whereby larger values of S correspond to higher hemoglobin oxygen saturation in the tissue in vivo, and lower values of S correspond to lower hemoglobin oxygen saturation in the tissue in vivo.

4. The method of claim 3, wherein:

(i) the value of x is corrected by a factor proportional to the integral of {the reference stratum minus the baseline} over region I;

wherein the baseline corresponds to zero reflectance or zero absorbance;

(ii) the value of y is corrected by a factor proportional to the integral of {the reference stratum minus the baseline} over region II; and

(i) the value of z is corrected by a factor proportional to the integral of {the reference stratum minus the baseline} over region III.

5. The method of claim 1, wherein:

(i) the value of x is corrected by a factor proportional to the integral of {the reference stratum minus the baseline} over the same portion of region I that is used to determine x;

wherein the baseline corresponds to zero reflectance or zero absorbance;

(ii) the value of y is corrected by a factor proportional to the integral of {the reference stratum minus the baseline} over the same portion of region II that is used to determine y; and

(i) the value of z is corrected by a factor proportional to the integral of {the reference stratum minus the baseline} over the same portion of region III that is used to determine z.

6. The method of claim 1, wherein the tissue is a blood vessel.

7. The method of claim 1, wherein the tissue is skin.

8. The method of claim 1, wherein the tissue is a retina or a blood vessel in a retina.

9. A method comprising repeating the method of claim 1 at a plurality of locations in the tissue, and plotting the inferred hemoglobin oxygen saturation levels in the tissue as a function of location.

10. A method of producing a plot according to claim 9 wherein the plot shows inferred hemoglobin oxygen saturation levels in a tissue.

11. A method to enhance the visual delineation of blood vessels in a tissue, said method comprising conducting the method claim 9 on the tissue, wherein the plot of hemoglobin oxygen saturation levels as a function of location delineates the location of the blood vessels.

12. A method for diagnosing abnormal hemoglobin oxygen saturation in a tissue, said method comprising conducting the method of claim 1 on the tissue, and identifying any abnormal values of x, y, or z as indicating abnormal hemoglobin oxygen saturation in the tissue.

13. The method of claim 12, wherein the diagnosis is conducted in a patient or in a tissue having a condition selected from the group consisting of glaucoma, diabetic retinopathy, hypertension, sickle cell disease, vascular disease, skin disorder, a wound, and a burn.